Metraipolis › archive › dc_05dc3cc7b5fe

Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary centre — Europe PMC PMID:41796282

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41796282
DOI
10.1186/s12885-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-05T00:09:45.576Z
SHA-256 of the archived text
001888da984e83a114f109899aff51e7786d8ed24eb29bbe6528513cd4781bc9
Stable URL of this page
https://metraipolis.com/documento/dc_05dc3cc7b5fe

How to cite

Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary centre — Europe PMC PMID:41796282 — Europe PMC (en), https://europepmc.org/article/MED/41796282 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05dc3cc7b5fe (Metraipolis archive dc_05dc3cc7b5fe, sha256 001888da984e83a114f109899aff51e7786d8ed24eb29bbe6528513cd4781bc9)
BibTeX
@misc{dc05dc3cc7b5fe,
  title = {Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary centre — Europe PMC PMID:41796282},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41796282},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05dc3cc7b5fe; sha256 001888da984e83a114f109899aff51e7786d8ed24eb29bbe6528513cd4781bc9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41796282. Agents can read the archived copy with the MCP tool read_document.